{
"id":"mk19_bb_gm_s38",
"subspecialtyId":"gm",
"title":"Benign Prostatic Hyperplasia",
"jsonContent":{
"type":"section",
"id":"mk19_bb_gm_s38",
"title":{
"__html":"Benign Prostatic Hyperplasia"
},
"titleNode":{
"type":"section-title",
"hlId":"9e6504",
"children":[
"Benign Prostatic Hyperplasia"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_gm_s38_1",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"b12f05",
"children":[
{
"type":"abbreviation",
"title":"benign prostatic hyperplasia",
"children":[
"BPH"
]
},
" leads to irritative symptoms (urinary urgency, frequency, and nocturia) and obstructive symptoms (decreased urinary stream, intermittency, incomplete emptying, and straining). BPH is diagnosed primarily by medical history and is supported by digital rectal examination. When a diagnosis of BPH has been established, the American Urological Association Symptom Index quantifies symptom severity and guides treatment decisions."
]
}
]
},
{
"type":"section",
"id":"mk19_bb_gm_s38_2",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"ac31d1",
"children":[
"For most patients, conservative treatment is sufficient (reduce fluid intake, stop contributing medications [diuretics, anticholinergics]). The two major BPH drug classes include:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"ca8f99",
"children":[
"α-adrenergic blockers (terazosin, tamsulosin, doxazosin, silodosin, and alfuzosin)"
]
},
" ",
{
"type":"list-item",
"hlId":"7860d6",
"children":[
"5-α reductase inhibitors (finasteride, dutasteride)"
]
},
" "
]
},
{
"type":"p",
"hlId":"0779c2",
"children":[
"α-Adrenergic blockers are superior to 5-α reductase inhibitors. α-Adrenergic blockers plus finasteride are more effective than either drug alone but are associated with increased adverse effects."
]
},
{
"type":"p",
"hlId":"171699",
"children":[
"Tadalafil, a PDE-5 inhibitor, improves lower urinary tract symptoms and may be used in patients regardless of comorbid erectile dysfunction."
]
},
{
"type":"p",
"hlId":"adc2aa",
"children":[
"Surgical treatment is indicated in patients with severe urinary symptoms, urinary retention, persistent hematuria, recurrent UTIs, or kidney disease clearly attributable to BPH."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"5acaeb",
"children":[
"Do not choose saw palmetto to treat lower urinary tract symptoms because of a lack of data supporting efficacy."
]
},
" ",
{
"type":"list-item",
"hlId":"851fb1",
"children":[
"Tadalafil combined with α-adrenergic blockers offers no advantages in symptom improvement over either agent alone and should not be offered."
]
},
" "
]
}
]
}
]
},
"tablesContent":{
}
}